Technology News and Research

RSS

Boston Scientific reports first use in Europe of Blazer Open-Irrigated Catheter

Boston Scientific Corporation today announced CE Mark approval and first use in Europe of its Blazer™ Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias. The product is being launched this quarter in select CE Mark countries.

4 May 2011

Immunetics receives NIH grant for new confirmatory test trial in Chagas' disease

Immunetics, Inc. today announced it has been awarded a $2.4 million, 3-year Phase II SBIR grant by the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, to support clinical trials of the company's new confirmatory test for Chagas' disease, a serious and potentially fatal parasitic infection.

4 May 2011

3M launches new Mobile Physician Solution

New mobile technology introduced today by 3M makes it easy for physicians to manage their daily schedule, review patient information, dictate progress notes, and log accurate charges all on a single mobile device in the palm of their hand.

4 May 2011

Tenet net operating revenues increase 7.1% to $2.506 billion for first quarter 2011

Tenet Healthcare Corporation today reported adjusted EBITDA of $379 million for the first quarter ended March 31, 2011, an increase of $81 million, or 27.2 percent, compared to $298 million for the first quarter of 2010.

4 May 2011

Henry Schein first quarter net sales increase 10.6% to $1.9 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended March 26, 2011.

3 May 2011

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

GenVec, Inc. today announced that it has entered into a second agreement with Merial, the animal health division of sanofi-aventis.

3 May 2011

Cynosure first quarter revenues increase 16% to $21.9 million

Cynosure, Inc. today announced financial results for the three months ended March 31, 2011.

3 May 2011

Nile Therapeutics initiates cenderitide Phase I trial in heart failure

Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced dosing of the first patient in a Phase I clinical trial investigating the use of subcutaneous cenderitide.

3 May 2011

First implantation of WiCS wireless cardiac pacing system performed in Germany

EBR Systems, Inc., a privately held clinical stage company, announced today the first human implants of the WiCS Wireless Cardiac Stimulation System.

3 May 2011

Vidyo, American Well partner to enable Online Care services

Vidyo, Inc., the first company to deliver personal telepresence, today announced a partnership with American Well, whose Online Care Suite connects providers and patients for live, immediate, and clinically meaningful encounters using the Web or phone.

3 May 2011

Transcend closes previously announced acquisition of DTS America

TRANSCEND SERVICES, INC., a leading provider of clinical documentation services to the U.S. healthcare market, announced today that it has closed its previously announced acquisition of Nashville, Tennessee-based DTS America, Inc., effective April 30, 2011.

3 May 2011

Retina Implant's second clinical trial initial findings presented at ARVO 2011

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of initial findings from their second clinical trial.

3 May 2011

Paulig Eye Surgery Center provides non-invasive alternative to keratoconus patients

The Paulig Eye Surgery Centre announces today that it has acquired advanced technology for performing Keraflex KXL, a new, non-invasive, non-surgical treatment for keratoconus. Surgeons at the Paulig Eye Surgery Centre will immediately begin treating patients using Avedro, Inc's Keraflex and KXL Systems.

3 May 2011

U.Va, Coulter Foundation partner for translational research in biomedical engineering

The University of Virginia and the Wallace H. Coulter Foundation have teamed to create a $20 million endowment to foster research collaboration between biomedical engineers and clinicians, with the goal of developing new technologies to improve patient care and human health.

3 May 2011

Astex earns GBP5.9 M milestone payment from GSK for fragment-based screening platform

Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has achieved multiple early milestones in its fragment-based drug discovery collaboration with GlaxoSmithKline which commenced in November 2009.

3 May 2011

Chromatrap Pro-A Spin Columns improve ChIP assay performance

Porvair Filtration Group has announced the launch of the first product, a ChIP kit containing 24 assays, based upon its novel Chromatrap™ Pro-A Chromatin ImmunoPrecipitation (ChIP) technology. The exciting new product has been enthusiastically tested at 12 beta sites around the world with excellent results and feedback.

From Chromatrap® - Porvair Sciences Ltd 3 May 2011

Winner Medical's PurCotton products introduced at MICF 2011

Winner Medical Group Inc. a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported that its wholly-owned subsidiary, Shenzhen PurCotton Technology Ltd., participated in the 13th China International Mother-Infant-Child Products Fair held in the China International Exhibition Center, Beijing, on April 14-16, 2011.

3 May 2011